This session examines the significant progress made in the field of enzymatic and chemical synthesis of DNA over the past year. The focus is on the evolving landscape following the introduction of key customer programs by several pioneering entities in the previous year. The discussion will highlight advancements in complex sequence synthesis, such as hairpins and Poly A’s, and the groundbreaking achievement of synthesizing sequences as long as 15,000 base pairs. The session also examines the impact of these developments on market growth and commercial viability. Additionally, the role of generative AI in this domain will be explored, assessing its influence on innovation and market dynamics. A panel of experts will discuss the outcomes and effectiveness of these customer-centric strategies, evaluating their success in market seeding and preparation for broader commercial launches. The insights shared in this session will offer a comprehensive overview of the current state and future prospects in the field of DNA synthesis, underscoring the intersection of technological innovation and market strategy.